When was BISC Global founded?

BISC Global was founded in 2017.

Where is BISC Global located?

BISC Global is headquartered in Ghent, Belgium.

Who is the current CEO of BISC Global?

Anandbir Singh Brar of BISC Global. They are also an angel investors in 1 startup.

How many employees does BISC Global have?

As of Jun 30, 2026, the latest employee count at BISC Global is 8.

Where does BISC Global rank among its competitors?

BISC Global ranks 337th amongst 709 active competitors, of which 72 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ONCOHOST, which secured $2.8M in May, 2025.

Who are the top competitors of BISC Global?

BISC Global's top competitors include Strand Life Sciences, BGI and Hexagon Bio. Among them, ONCOHOST secured the most recent funding round in May, 2025.

BISC Global - 2026 Company Profile, Team, Competitors & Financials

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BISC Global CIN: 0673.977.180 , Belgium, Active	Apr 06, 2017	-	15 (As on Jun 30, 2022)	-

BISC Global's employee count trend

BISC Global has 8 employees as of Jun 26. Here is BISC Global's employee count trend over the years:

Uncover BISC Global's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BISC Global include Strand Life Sciences, BGI and Hexagon Bio. Here is the list of Top 10 competitors of BISC Global, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	73/100
2nd	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
3rd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
4th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	60/100
5th	Enara Bio 2016, Oxford (United Kingdom), Series B	Developer of T-cell based cancer-cell interface for therapeutics	$84.1M	M Ventures, SV Health Investors & 36 others	53/100
6th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Ampersand Capital & 6 others	53/100
7th	Allelica 2017, Rome (Italy), Seed	Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition	$1.81M	Valor Ventures, Pi Campus & 3 others	52/100
8th	Berry Genomics 2010, Beijing (China), Public	Provider of genetic testing products and tests	$16M	Legend Capital, TMCP & 6 others	50/100
9th	Dante Omics 2016, New York City (United States), Unfunded	Provider of genomic services and solutions for researchers, laboratories, and healthcare professionals	-	-	48/100
10th	Amplia Therapeutics 2000, North Melbourne (Australia), Public	Developer of therapies for treating cancer and pulmonary fibrosis	-	-	47/100
337th	BISC Global 2017, Ghent (Belgium), Acquired	Provider of bioinformatics and biostatics services for life science companies	-	-	25/100